NeuroOne Medical Technologies Corporation (NMTC)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-Q/A | Q2-2026 | |||
| 10-QLatest | Q2-2026 | 8-K (2026-05-12) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-02-17) · 99.1 | ||
| 10-K/A | FY-2025 | |||
| 10-KLatest | FY-2025 | 8-K (2025-12-17) · 99.1 | 8-K (2025-10-06) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-08-14) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-05-13) · 99.1 · 99.2 | ||
| 10-Q | Q1-2025 | 8-K (2025-02-12) · 99.1 | 8-K (2025-01-10) · 99.1 · 99.2 | ||
| 10-K | FY-2024 | 8-K (2024-12-17) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-08-14) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-05-14) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-02-13) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2023-12-14) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-08-14) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Document and Entity Information | ||
| Audit Information | — |
|
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Statements of Operations | ||
| Statements of Changes In Stockholders Equity (unaudited) | ||
| Statements of Operations (P) | ||
| Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses and Other Liabilities | ||
| Commitments and Contingencies | ||
| Concentrations | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt Financing | ||
| Deferred Contribution Plan | — |
|
| Defined Contribution Plan | ||
| Description of Business and Basis of Presentation | — |
|
| Going Concern | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Liquidity | — |
|
| Organization and Nature of Operations | — |
|
| Pay Vs Performance Disclosure | ||
| Segment Reporting | ||
| Stock-based Compensation | ||
| Stockholders Equity | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Supplemental Balance Sheet Information | ||
| Zimmer Development Agreement | ||
| Zimmer Development Agreement and Other Product Revenue | ||
| Zimmer Distribution Agreement and Other Product Revenue | ||